From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: 8+1 may not be worth 9 at Bushveld

By Tom Winnifrith | Monday 23 October 2017


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


In a wide ranging bearcast I ask whether the demerger of Afratin by Bushveld (BMN) will necessarily create value for shareholders. Then it is onto the read acrosses from Pendragon's (PDG) statement, not least for BCA Marketplace (BCA). Then I look at the scandsalous cash-piss by the evil fake news poll tax funded BBC on Interserve (IRV) and what it means for Interserve. I look at MySquar (MYSQ) and how soon it is a zero, UK Oil & Gas (UKOG), Andalas (ADL) and then onto SalvaRx (SALV) where, the fugitive from justice in South Korea, old Jim Mellon has pumped in more cash but where a real crash crunch clearly looms.  Finally a few words on TrakM8 (TRAK)

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

Time left: 14:07:12